SI
AVXL icon

Saxon Interests’s Anavex Life Sciences AVXL Stock Holding History

Saxon Interests’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,998
Closed -$60.5K – 227
2025
Q4 		$60.5K Sell
16,998
-823
-5% -$5.04K 0.02% 207
2025
Q3 		$172K Sell
17,821
-27
-0.2% -$274 0.07% 203
2025
Q2 		$153K Hold
17,848
– – 0.07% 179
2025
Q1 		$153K Sell
17,848
-7,839
-31% -$74K 0.07% 179
2024
Q4 		$276K Sell
25,687
-1,689
-6% -$13K 0.12% 147
2024
Q3 		$155K Buy
27,376
+677
+3% +$3.91K 0.07% 178
2024
Q2 		$113K Hold
26,699
– – 0.05% 174
2024
Q1 		$136K Buy
+26,699
New +$150K 0.06% 187

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Saxon Interests's AVXL Position: Q1 2026 in Review

Saxon Interests sold out of Anavex Life Sciences (AVXL) in Q1 2026, closing a stake of 16,998 shares — an estimated $60.5K sold.

Saxon Interests first reported a position in AVXL in Q1 2024 and held it in 8 quarters. The position peaked at $276K in Q4 2024. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Saxon Interests reported no remaining Anavex Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Saxon Interests sold 16,998 Anavex Life Sciences shares in Q1 2026, an estimated $60.5K.
  • Saxon Interests first reported a position in Anavex Life Sciences in Q1 2024 and held it in 8 quarters.
  • Saxon Interests's Anavex Life Sciences position peaked at $276K in Q4 2024.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Saxon Interests's 13F filing for Q1 2026, filed 29 Apr 2026.